$AHR
American Healthcare REIT, Inc.

2020 Q3 Form 10-Q Financial Statement

#000163297020000075 Filed on November 13, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2019 Q3
Revenue $18.95M $31.12M
YoY Change -39.11% 39.66%
Cost Of Revenue $17.40M $4.929M
YoY Change 252.95% 54.66%
Gross Profit $1.551M $26.19M
YoY Change -94.08% 37.16%
Gross Profit Margin 8.19% 84.16%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $7.966M $6.806M
YoY Change 17.04% 55.25%
% of Gross Profit 513.6% 25.99%
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $4.839M $4.140M
YoY Change 16.88% 158.43%
% of Operating Profit
Other Income/Expense, Net -$6.822M $4.608M
YoY Change -248.05% 188.72%
Pretax Income -$5.191M -$1.911M
YoY Change 171.64% 12.48%
Income Tax -$39.00K $7.000K
% Of Pretax Income
Net Earnings -$4.920M -$1.899M
YoY Change 159.08% 16.43%
Net Earnings / Revenue -25.97% -6.1%
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q3 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $22.69M $22.45M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles $68.64M $73.42M
YoY Change -6.52% 14.55%
Long-Term Investments $47.97M $47.30M
YoY Change 1.42%
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $1.111B $1.038B
YoY Change 7.12% 37.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $549.6M $439.2M
YoY Change 25.13% 69.64%
SHAREHOLDERS EQUITY
Retained Earnings -$172.4M -$119.8M
YoY Change 43.88% 133.65%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $558.3M
YoY Change
Total Liabilities & Shareholders Equity $1.111B $1.038B
YoY Change 7.12% 37.12%

Cashflow Statement

Concept 2020 Q3 2019 Q3
OPERATING ACTIVITIES
Net Income -$4.920M -$1.899M
YoY Change 159.08% 16.43%
Depreciation, Depletion And Amortization $7.966M $6.806M
YoY Change 17.04% 55.25%
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei City Area Code
CityAreaCode
949
dei Local Phone Number
LocalPhoneNumber
270-9200
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001632970
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-55775
dei Entity Registrant Name
EntityRegistrantName
GRIFFIN-AMERICAN HEALTHCARE REIT IV, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-2887436
dei Entity Address Address Line1
EntityAddressAddressLine1
18191 Von Karman Avenue
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 300
dei Entity Address City Or Town
EntityAddressCityOrTown
Irvine
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92612
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Shell Company
EntityShellCompany
false
CY2020Q3 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
928066000 USD
CY2019Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
895060000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22690000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15290000 USD
CY2020Q3 us-gaap Accounts Receivable Net
AccountsReceivableNet
3262000 USD
CY2019Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
4608000 USD
CY2020Q3 us-gaap Restricted Cash
RestrictedCash
706000 USD
CY2019Q4 us-gaap Restricted Cash
RestrictedCash
556000 USD
CY2020Q3 us-gaap Earnest Money Deposits
EarnestMoneyDeposits
0 USD
CY2019Q4 us-gaap Earnest Money Deposits
EarnestMoneyDeposits
1915000 USD
CY2020Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
68636000 USD
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
74023000 USD
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
14163000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
14255000 USD
CY2020Q3 us-gaap Other Assets
OtherAssets
73967000 USD
CY2019Q4 us-gaap Other Assets
OtherAssets
62620000 USD
CY2020Q3 us-gaap Assets
Assets
1111490000 USD
CY2019Q4 us-gaap Assets
Assets
1068327000 USD
CY2020Q3 us-gaap Secured Debt
SecuredDebt
17974000 USD
CY2019Q4 us-gaap Secured Debt
SecuredDebt
26070000 USD
CY2020Q3 us-gaap Line Of Credit
LineOfCredit
479500000 USD
CY2019Q4 us-gaap Line Of Credit
LineOfCredit
396800000 USD
CY2020Q3 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
27436000 USD
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
32033000 USD
CY2020Q3 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
987000 USD
CY2019Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
1016000 USD
CY2020Q3 us-gaap Off Market Lease Unfavorable
OffMarketLeaseUnfavorable
1362000 USD
CY2019Q4 us-gaap Off Market Lease Unfavorable
OffMarketLeaseUnfavorable
1601000 USD
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
9975000 USD
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
9858000 USD
CY2020Q3 us-gaap Other Liabilities
OtherLiabilities
12343000 USD
CY2019Q4 us-gaap Other Liabilities
OtherLiabilities
9408000 USD
CY2020Q3 us-gaap Liabilities
Liabilities
549577000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
476786000 USD
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q3 us-gaap Redeemable Noncontrolling Interest Equity Fair Value
RedeemableNoncontrollingInterestEquityFairValue
2697000 USD
CY2019Q4 us-gaap Redeemable Noncontrolling Interest Equity Fair Value
RedeemableNoncontrollingInterestEquityFairValue
1462000 USD
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
200000000 shares
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
200000000 shares
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
729923000 USD
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
719894000 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-172436000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-130613000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
558296000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
590079000 USD
CY2020Q3 us-gaap Minority Interest
MinorityInterest
920000 USD
CY2019Q4 us-gaap Minority Interest
MinorityInterest
0 USD
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
559216000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
590079000 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1111490000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1068327000 USD
CY2020Q3 us-gaap Line Of Credit
LineOfCredit
479500000 USD
CY2019Q4 us-gaap Line Of Credit
LineOfCredit
396800000 USD
CY2020Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
21519000 USD
CY2019Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
19253000 USD
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
64824000 USD
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
53280000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18948000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11865000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
51863000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34053000 USD
CY2020Q3 gahr Government Grant Income From Cares Act
GovernmentGrantIncomeFromCARESAct
864000 USD
CY2019Q3 gahr Government Grant Income From Cares Act
GovernmentGrantIncomeFromCARESAct
0 USD
gahr Government Grant Income From Cares Act
GovernmentGrantIncomeFromCARESAct
864000 USD
gahr Government Grant Income From Cares Act
GovernmentGrantIncomeFromCARESAct
0 USD
CY2020Q3 gahr Revenuesand Government Grant Income From Cares Act
RevenuesandGovernmentGrantIncomeFromCARESAct
41331000 USD
CY2019Q3 gahr Revenuesand Government Grant Income From Cares Act
RevenuesandGovernmentGrantIncomeFromCARESAct
31118000 USD
gahr Revenuesand Government Grant Income From Cares Act
RevenuesandGovernmentGrantIncomeFromCARESAct
117551000 USD
gahr Revenuesand Government Grant Income From Cares Act
RevenuesandGovernmentGrantIncomeFromCARESAct
87333000 USD
CY2020Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
5905000 USD
CY2019Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
4929000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
17723000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
14238000 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
17397000 USD
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9884000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
44856000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
28194000 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3672000 USD
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3982000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11960000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11413000 USD
CY2020Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
57000 USD
CY2019Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
74000 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
74000 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
1492000 USD
CY2020Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
12669000 USD
CY2019Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
9552000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
37919000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
35561000 USD
CY2020Q3 us-gaap Costs And Expenses
CostsAndExpenses
39700000 USD
CY2019Q3 us-gaap Costs And Expenses
CostsAndExpenses
28421000 USD
us-gaap Costs And Expenses
CostsAndExpenses
112532000 USD
us-gaap Costs And Expenses
CostsAndExpenses
90898000 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
4839000 USD
CY2019Q3 us-gaap Interest Expense
InterestExpense
4140000 USD
us-gaap Interest Expense
InterestExpense
15123000 USD
us-gaap Interest Expense
InterestExpense
11532000 USD
CY2020Q3 us-gaap Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
1450000 USD
CY2019Q3 us-gaap Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
-402000 USD
us-gaap Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
-2302000 USD
us-gaap Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
-5401000 USD
CY2020Q3 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
3064000 USD
CY2019Q3 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
0 USD
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
3064000 USD
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
0 USD
CY2020Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-377000 USD
CY2019Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-79000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
952000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
185000 USD
CY2020Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
8000 USD
CY2019Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
13000 USD
us-gaap Interest And Other Income
InterestAndOtherIncome
278000 USD
us-gaap Interest And Other Income
InterestAndOtherIncome
162000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5191000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1911000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14240000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-20151000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-39000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17000 USD
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-5152000 USD
CY2019Q3 us-gaap Profit Loss
ProfitLoss
-1918000 USD
us-gaap Profit Loss
ProfitLoss
-14240000 USD
us-gaap Profit Loss
ProfitLoss
-20168000 USD
CY2020Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-232000 USD
CY2019Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-19000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-608000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-76000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-4920000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-1899000 USD
us-gaap Net Income Loss
NetIncomeLoss
-13632000 USD
us-gaap Net Income Loss
NetIncomeLoss
-20092000 USD
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.17
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.26
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
80788359 shares
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
79502193 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
80498693 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
77894326 shares
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
569002000 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
5000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
4247000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
29000 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
44000 USD
CY2020Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
706000 USD
CY2020Q3 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
22000 USD
CY2020Q3 gahr Adjustmentsto Additional Paidin Capital Fair Value Adjustmentto Redeemable Noncontrolling Interests
AdjustmentstoAdditionalPaidinCapitalFairValueAdjustmenttoRedeemableNoncontrollingInterests
208000 USD
CY2020Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.10
CY2020Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
8150000 USD
CY2020Q3 gahr Net Income Lossincluding Portion Attributableto Noncontrolling Interest Excluding Preferred Stock Dividend
NetIncomeLossincludingPortionAttributabletoNoncontrollingInterestExcludingPreferredStockDividend
-5025000 USD
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
559216000 USD
CY2019Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
606949000 USD
CY2019Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-14000 USD
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
66000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
6599000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
29000 USD
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
43000 USD
CY2019Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
2823000 USD
CY2019Q3 gahr Adjustmentsto Additional Paidin Capital Fair Value Adjustmentto Redeemable Noncontrolling Interests
AdjustmentstoAdditionalPaidinCapitalFairValueAdjustmenttoRedeemableNoncontrollingInterests
23000 USD
CY2019Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.15
CY2019Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
12030000 USD
CY2019Q3 gahr Net Income Lossincluding Portion Attributableto Noncontrolling Interest Excluding Preferred Stock Dividend
NetIncomeLossincludingPortionAttributabletoNoncontrollingInterestExcludingPreferredStockDividend
-1899000 USD
CY2019Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
596897000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
590079000 USD
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
67000 USD
us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
15681000 USD
us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
15681000 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
43000 USD
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
128000 USD
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
5349000 USD
us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
1250000 USD
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
54000 USD
gahr Adjustmentsto Additional Paidin Capital Fair Value Adjustmentto Redeemable Noncontrolling Interests
AdjustmentstoAdditionalPaidinCapitalFairValueAdjustmenttoRedeemableNoncontrollingInterests
530000 USD
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.35
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
28191000 USD
gahr Net Income Lossincluding Portion Attributableto Noncontrolling Interest Excluding Preferred Stock Dividend
NetIncomeLossincludingPortionAttributabletoNoncontrollingInterestExcludingPreferredStockDividend
-13908000 USD
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
559216000 USD
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
557672000 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
88715000 USD
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
7385000 USD
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
7385000 USD
us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
19056000 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
43000 USD
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
121000 USD
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
6192000 USD
gahr Adjustmentsto Additional Paidin Capital Fair Value Adjustmentto Redeemable Noncontrolling Interests
AdjustmentstoAdditionalPaidinCapitalFairValueAdjustmenttoRedeemableNoncontrollingInterests
65000 USD
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.45
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
34976000 USD
gahr Net Income Lossincluding Portion Attributableto Noncontrolling Interest Excluding Preferred Stock Dividend
NetIncomeLossincludingPortionAttributabletoNoncontrollingInterestExcludingPreferredStockDividend
-20092000 USD
CY2019Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
596897000 USD
CY2020Q3 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
127000 USD
CY2019Q3 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
19000 USD
us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
332000 USD
us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
76000 USD
us-gaap Profit Loss
ProfitLoss
-14240000 USD
us-gaap Profit Loss
ProfitLoss
-20168000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
37919000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
35561000 USD
gahr Other Amortization
OtherAmortization
2084000 USD
gahr Other Amortization
OtherAmortization
1869000 USD
us-gaap Straight Line Rent Adjustments
StraightLineRentAdjustments
-3440000 USD
us-gaap Straight Line Rent Adjustments
StraightLineRentAdjustments
-1886000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
171000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
164000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
952000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
185000 USD
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
0 USD
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
75000 USD
us-gaap Increase Decrease In Other Financial Instruments Used In Operating Activities
IncreaseDecreaseInOtherFinancialInstrumentsUsedInOperatingActivities
-2302000 USD
us-gaap Increase Decrease In Other Financial Instruments Used In Operating Activities
IncreaseDecreaseInOtherFinancialInstrumentsUsedInOperatingActivities
-5401000 USD
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
3064000 USD
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
0 USD
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-1347000 USD
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-3854000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1654000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-256000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3436000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
6023000 USD
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
27000 USD
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
142000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-121000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-674000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
29943000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
30432000 USD
us-gaap Payments To Acquire And Develop Real Estate
PaymentsToAcquireAndDevelopRealEstate
68032000 USD
us-gaap Payments To Acquire And Develop Real Estate
PaymentsToAcquireAndDevelopRealEstate
153923000 USD
us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
6729000 USD
us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
4388000 USD
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
0 USD
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
600000 USD
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
0 USD
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
1013000 USD
us-gaap Payments For Proceeds From Deposits On Real Estate Acquisitions
PaymentsForProceedsFromDepositsOnRealEstateAcquisitions
0 USD
us-gaap Payments For Proceeds From Deposits On Real Estate Acquisitions
PaymentsForProceedsFromDepositsOnRealEstateAcquisitions
-2547000 USD
gahr Paymentsfor Preacquisitionexpenses
PaymentsforPreacquisitionexpenses
0 USD
gahr Paymentsfor Preacquisitionexpenses
PaymentsforPreacquisitionexpenses
179000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-74761000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-155530000 USD
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
8166000 USD
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
459000 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
140800000 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
165600000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
58100000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
83100000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
43000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
65000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
90438000 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
4876000 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
17457000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
13932000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
15446000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
5349000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
6192000 USD
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
1250000 USD
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
0 USD
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
54000 USD
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
0 USD
gahr Proceedsfrom Redeemable Noncontrolling Interests
ProceedsfromRedeemableNoncontrollingInterests
1118000 USD
gahr Proceedsfrom Redeemable Noncontrolling Interests
ProceedsfromRedeemableNoncontrollingInterests
151000 USD
gahr Paymentsto Redeemable Noncontrolling Interest
PaymentstoRedeemableNoncontrollingInterest
81000 USD
gahr Paymentsto Redeemable Noncontrolling Interest
PaymentstoRedeemableNoncontrollingInterest
0 USD
gahr Payments For Proceeds From Security Deposits Financing Activities
PaymentsForProceedsFromSecurityDepositsFinancingActivities
-199000 USD
gahr Payments For Proceeds From Security Deposits Financing Activities
PaymentsForProceedsFromSecurityDepositsFinancingActivities
-94000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
52368000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
133376000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
7550000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
8278000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15846000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14590000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23396000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22868000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15290000 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14388000 USD
CY2019Q4 us-gaap Restricted Cash
RestrictedCash
556000 USD
CY2018Q4 us-gaap Restricted Cash
RestrictedCash
202000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15846000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14590000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22690000 USD
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22448000 USD
CY2020Q3 us-gaap Restricted Cash
RestrictedCash
706000 USD
CY2019Q3 us-gaap Restricted Cash
RestrictedCash
420000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23396000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22868000 USD
us-gaap Interest Paid Net
InterestPaidNet
13777000 USD
us-gaap Interest Paid Net
InterestPaidNet
9369000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
88000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
21000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2182000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
4205000 USD
gahr Tenant Improvement Overage
TenantImprovementOverage
636000 USD
gahr Tenant Improvement Overage
TenantImprovementOverage
195000 USD
gahr Preacquisitionexpenses Incurredbut Notyet Paid
PreacquisitionexpensesIncurredbutNotyetPaid
0 USD
gahr Preacquisitionexpenses Incurredbut Notyet Paid
PreacquisitionexpensesIncurredbutNotyetPaid
184000 USD
gahr Increase Decreaseto Rightof Use Asset
IncreaseDecreasetoRightofUseAsset
0 USD
gahr Increase Decreaseto Rightof Use Asset
IncreaseDecreasetoRightofUseAsset
2196000 USD
us-gaap Noncash Or Part Noncash Acquisition Other Assets Acquired1
NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1
196000 USD
us-gaap Noncash Or Part Noncash Acquisition Other Assets Acquired1
NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1
86000 USD
us-gaap Noncash Or Part Noncash Acquisition Debt Assumed1
NoncashOrPartNoncashAcquisitionDebtAssumed1
0 USD
us-gaap Noncash Or Part Noncash Acquisition Debt Assumed1
NoncashOrPartNoncashAcquisitionDebtAssumed1
9735000 USD
us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
201000 USD
us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
783000 USD
gahr Increase Decreaseto Operating Lease Liability
IncreaseDecreasetoOperatingLeaseLiability
0 USD
gahr Increase Decreaseto Operating Lease Liability
IncreaseDecreasetoOperatingLeaseLiability
4489000 USD
us-gaap Noncash Or Part Noncash Acquisition Other Liabilities Assumed1
NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1
11000 USD
us-gaap Noncash Or Part Noncash Acquisition Other Liabilities Assumed1
NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1
1343000 USD
us-gaap Stock Issued1
StockIssued1
15681000 USD
us-gaap Stock Issued1
StockIssued1
19056000 USD
CY2020Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
2664000 USD
CY2019Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
3933000 USD
CY2020Q3 gahr Accruedstockholderservicingfee
Accruedstockholderservicingfee
7667000 USD
CY2019Q3 gahr Accruedstockholderservicingfee
Accruedstockholderservicingfee
14241000 USD
us-gaap Nature Of Operations
NatureOfOperations
<div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. Organization and Description of Business </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Griffin-American Healthcare REIT IV, Inc., a Maryland corporation, was incorporated on January 23, 2015 and therefore we consider that our date of inception. We were initially capitalized on February 6, 2015. We invest in a diversified portfolio of real estate properties, focusing primarily on medical office buildings, skilled nursing facilities, senior housing and other healthcare-related facilities. We also operate healthcare-related facilities utilizing the structure permitted by the REIT Investment Diversification and Empowerment Act of 2007, which is commonly referred to as a “RIDEA” structure (the provisions of the Internal Revenue Code of 1986, as amended, or the Code, authorizing the RIDEA structure were enacted as part of the Housing and Economic Recovery Act of 2008). We generally seek investments that produce current income. We qualified to be taxed as a real estate investment trust, or REIT, under the Code for federal income tax purposes beginning with our taxable year ended December 31, 2016, and we intend to continue to qualify to be taxed as a REIT.</span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 16, 2016, we commenced our initial public offering, or our initial offering, in which we were initially offering to the public up to $3,150,000,000 in shares of our Class T common stock, consisting of up to $3,000,000,000 in shares of our Class T common stock in the primary portion of our initial offering and up to $150,000,000 in shares of our Class T common stock pursuant to our distribution reinvestment plan, as amended, or the DRIP. Effective June 17, 2016, we reallocated certain of the unsold shares of Class T common stock being offered and began offering shares of Class I common stock, such that we were offering up to approximately $2,800,000,000 in shares of Class T common stock and $200,000,000 in shares of Class I common stock in the primary portion of our initial offering, and up to an aggregate of $150,000,000 in shares of our Class T and Class I common stock pursuant to the DRIP, aggregating up to $3,150,000,000. On February 15, 2019, we terminated our initial offering, and as of such date, we sold 75,639,681 aggregate shares of our Class T and Class I common stock, or approximately $754,118,000, and a total of $31,021,000 in distributions were reinvested that resulted in 3,253,535 shares of our common stock being issued pursuant to the DRIP portion of our initial offering.</span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 18, 2019, we filed a Registration Statement on Form S-3 under the Securities Act of 1933, as amended, or the Securities Act, to register a maximum of $100,000,000 of additional shares of our common stock to be issued pursuant to the DRIP, or the 2019 DRIP Offering. The Registration Statement on Form S-3 was automatically effective with the United States Securities and Exchange Commission, or the SEC, upon its filing. We commenced offering shares pursuant to the 2019 DRIP Offering on March 1, 2019, following the termination of our initial offering on February 15, 2019. See Note 12, Equity — Distribution Reinvestment Plan, for a further discussion. As of September 30, 2020, a total of $37,290,000 in distributions were reinvested that resulted in 3,903,895 shares of our common stock being issued pursuant to the 2019 DRIP Offering. We collectively refer to the DRIP portion of our initial offering and the 2019 DRIP Offering as our DRIP Offerings.</span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conduct substantially all of our operations through Griffin-American Healthcare REIT IV Holdings, LP, or our operating partnership. We are externally advised by Griffin-American Healthcare REIT IV Advisor, LLC, or our advisor, pursuant to an advisory agreement, or the Advisory Agreement, between us and our advisor. The Advisory Agreement was effective as of February 16, 2016 and had a one-year initial term, subject to successive one-year renewals upon the mutual consent of the parties. The Advisory Agreement was last renewed pursuant to the mutual consent of the parties on February 12, 2020 and expires on February 16, 2021. Our advisor uses its best efforts, subject to the oversight and review of our board of directors, or our board, to, among other things, research, identify, review and make investments in and dispositions of properties and securities on our behalf consistent with our investment policies and objectives. Our advisor performs its duties and responsibilities under the Advisory Agreement as our fiduciary. Our advisor is 75.0% owned and managed by wholly owned subsidiaries of American Healthcare Investors, LLC, or American Healthcare Investors, and 25.0% owned by a wholly owned subsidiary of Griffin Capital Company, LLC, or Griffin Capital, or collectively, our co-sponsors. American Healthcare Investors is 47.1% owned by AHI Group Holdings, LLC, or AHI Group Holdings, 45.1% indirectly owned by Colony Capital, Inc. (NYSE: CLNY), or Colony Capital, and 7.8% owned by James F. Flaherty III, a former partner of Colony Capital. We are not affiliated with Griffin Capital, Griffin Capital Securities, LLC, or our dealer manager, Colony Capital or Mr. Flaherty; however, we are affiliated with our advisor, American Healthcare Investors and AHI Group Holdings.</span></div><div style="margin-top:8pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently operate through four reportable business segments: medical office buildings, senior housing, senior housing — RIDEA and skilled nursing facilities. As of September 30, 2020, we had completed 46 property acquisitions whereby we owned 89 properties, comprising 94 buildings, or approximately 4,863,000 square feet of gross leasable area, or GLA, for an aggregate contract purchase price of $1,089,071,000. As of September 30, 2020, we also owned a 6.0% interest in a joint venture which owns a portfolio of integrated senior health campuses and ancillary businesses.</span></div>
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2015-01-23
us-gaap Operations Commenced Date1
OperationsCommencedDate1
2015-02-06
CY2016Q1 gahr Aggregate Maximum Amount Of Common Stock Issuable Under Public Offering
AggregateMaximumAmountOfCommonStockIssuableUnderPublicOffering
3150000000 USD
CY2016Q2 gahr Aggregate Reallocated Maximum Amountof Common Stock Issuable Under Primary Public Offering
AggregateReallocatedMaximumAmountofCommonStockIssuableUnderPrimaryPublicOffering
3150000000 USD
us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
31021000 USD
us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
3253535 shares
CY2017 gahr Advisory Agreement Term
AdvisoryAgreementTerm
P1Y
CY2017 gahr Advisory Agreement Term
AdvisoryAgreementTerm
P1Y
CY2020Q3 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
4 segment
gahr Numberof Acquisitions Completedfrom Unaffiliated Parties
NumberofAcquisitionsCompletedfromUnaffiliatedParties
46 Acquisition
gahr Numberof Properties Acquiredfrom Unaffiliated Parties
NumberofPropertiesAcquiredfromUnaffiliatedParties
89 Property
gahr Number Of Buildings Acquired From Unaffiliated Parties
NumberOfBuildingsAcquiredFromUnaffiliatedParties
94 Building
CY2020Q3 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
4863000 sqft
gahr Acquisition Aggregated Cost Of Acquired Properties Purchase Price
AcquisitionAggregatedCostOfAcquiredPropertiesPurchasePrice
1089071000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of our accompanying condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, as well as the disclosure of contingent assets and liabilities, at the date of our condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Significant items subject to such estimates and assumptions include, but are not limited to, the initial and recurring valuation of certain assets acquired and liabilities assumed through property acquisitions, revenues and grant income, allowance for credit losses, impairment of long-lived assets and contingencies. These estimates are made and evaluated on an on-going basis using information that is currently available as well as various other assumptions believed to be reasonable under the circumstances. Actual results could differ from those estimates, perhaps in material adverse ways, and those estimates could be different under different assumptions or conditions.</span></div>
gahr Government Grant Income From Cares Act
GovernmentGrantIncomeFromCARESAct
864000 USD
CY2020Q3 gahr Government Grant Income From Cares Act
GovernmentGrantIncomeFromCARESAct
864000 USD
CY2019Q3 gahr Government Grant Income From Cares Act
GovernmentGrantIncomeFromCARESAct
0 USD
gahr Government Grant Income From Cares Act
GovernmentGrantIncomeFromCARESAct
0 USD
us-gaap Financing Receivable Allowance For Credit Losses Policy For Uncollectible Amounts
FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts
<div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tenant and Resident Receivables and Allowances</span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2020, we adopted Financial Accounting Standards Board, or FASB, Accounting Standards Codification, or ASC, Topic 326, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments Credit Losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, or ASC Topic 326. We adopted ASC Topic 326 using the modified retrospective approach whereby the cumulative effect of adoption was recognized on the adoption date and prior periods were not restated. There was no net cumulative effect adjustment to retained earnings as of January 1, 2020. </span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Resident receivables are carried net of an allowance for credit losses. An allowance is maintained for estimated losses resulting from the inability of residents and payors to meet the contractual obligations under their lease or service agreements. Substantially all of such allowances are recorded as direct reductions of resident fees and services revenue as contractual adjustments provided to third-party payors or implicit price concessions in our accompanying condensed consolidated statements of operations. Our determination of the adequacy of these allowances is based primarily upon evaluations of historical loss experience, the residents’ financial condition, security deposits, cash collection patterns by payor and by state, current economic conditions, future expectations in estimating credit losses and other relevant factors. Tenant receivables and unbilled deferred rent receivables are reduced for uncollectible amounts, which are recognized as direct reductions of real estate revenue in our accompanying condensed consolidated statements of operations.</span></div>
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1653000 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
902000 USD
us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
937000 USD
us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
1776000 USD
us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
346000 USD
gahr Financing Receivable Allowancefor Credit Loss Collectionsor Adjustments
FinancingReceivableAllowanceforCreditLossCollectionsorAdjustments
126000 USD
gahr Financing Receivable Allowancefor Credit Loss Collectionsor Adjustments
FinancingReceivableAllowanceforCreditLossCollectionsorAdjustments
766000 USD
us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
60000 USD
CY2020Q3 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
1001510000 USD
CY2019Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
946118000 USD
CY2020Q3 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
73444000 USD
CY2019Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
51058000 USD
CY2020Q3 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
928066000 USD
CY2019Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
895060000 USD
CY2020Q3 us-gaap Depreciation
Depreciation
7966000 USD
CY2019Q3 us-gaap Depreciation
Depreciation
6806000 USD
us-gaap Depreciation
Depreciation
23698000 USD
us-gaap Depreciation
Depreciation
20256000 USD
CY2020Q2 gahr Paymentsof Earn Out
PaymentsofEarnOut
1483000 USD
gahr Capitalized Acquisition Costsand Fees Additions
CapitalizedAcquisitionCostsandFeesAdditions
2538000 USD
CY2020Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
68636000 USD
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
74023000 USD
CY2020Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4728000 USD
CY2019Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2807000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
14361000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
15429000 USD
us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P8Y9M18D
CY2019 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P9Y6M
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
4535000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
11920000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
8648000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
7384000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
6155000 USD
CY2020Q3 gahr Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
29646000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
68288000 USD
CY2020Q3 us-gaap Equity Method Investments
EquityMethodInvestments
47968000 USD
CY2019Q4 us-gaap Equity Method Investments
EquityMethodInvestments
47016000 USD
CY2020Q3 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
11458000 USD
CY2019Q4 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
8018000 USD
CY2020Q3 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
10007000 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
2380000 USD
CY2020Q3 us-gaap Deferred Costs Leasing Accumulated Amortization
DeferredCostsLeasingAccumulatedAmortization
336000 USD
CY2019Q4 us-gaap Deferred Costs Leasing Accumulated Amortization
DeferredCostsLeasingAccumulatedAmortization
174000 USD
CY2020Q3 us-gaap Deferred Costs Leasing Net
DeferredCostsLeasingNet
2340000 USD
CY2019Q4 us-gaap Deferred Costs Leasing Net
DeferredCostsLeasingNet
1623000 USD
CY2020Q3 us-gaap Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
2927000 USD
CY2019Q4 us-gaap Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
1517000 USD
CY2020Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
2194000 USD
CY2019Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
3583000 USD
CY2020Q3 us-gaap Other Assets
OtherAssets
73967000 USD
CY2019Q4 us-gaap Other Assets
OtherAssets
62620000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1410000 USD
CY2020Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
471000 USD
CY2019Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
484000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1606000 USD
CY2020Q3 gahr Amortization Expense On Lease Commissions
AmortizationExpenseOnLeaseCommissions
84000 USD
CY2019Q3 gahr Amortization Expense On Lease Commissions
AmortizationExpenseOnLeaseCommissions
29000 USD
gahr Amortization Expense On Lease Commissions
AmortizationExpenseOnLeaseCommissions
189000 USD
gahr Amortization Expense On Lease Commissions
AmortizationExpenseOnLeaseCommissions
81000 USD
CY2020Q3 gahr Joint Ventureunamortizedbasisdifference
JointVentureunamortizedbasisdifference
16905000 USD
CY2019Q4 gahr Joint Ventureunamortizedbasisdifference
JointVentureunamortizedbasisdifference
17248000 USD
CY2020Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
18933000 USD
CY2020Q3 us-gaap Secured Debt
SecuredDebt
17974000 USD
CY2019Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
27099000 USD
CY2019Q4 us-gaap Secured Debt
SecuredDebt
26070000 USD
CY2020Q3 gahr Number Of Fixed Rate Mortgage Loans Payable
NumberOfFixedRateMortgageLoansPayable
3 MortgageLoan
CY2019Q4 gahr Number Of Fixed Rate Mortgage Loans Payable
NumberOfFixedRateMortgageLoansPayable
4 MortgageLoan
gahr Payoffofmortgageloanpayable
Payoffofmortgageloanpayable
7738000 USD
CY2019Q4 us-gaap Secured Debt
SecuredDebt
26070000 USD
CY2018Q4 us-gaap Secured Debt
SecuredDebt
16892000 USD
gahr Borrowingsandassumptionsonmortgageloanspayablenet
Borrowingsandassumptionsonmortgageloanspayablenet
0 USD
gahr Borrowingsandassumptionsonmortgageloanspayablenet
Borrowingsandassumptionsonmortgageloanspayablenet
9735000 USD
gahr Amortizationofdeferredfinancingcostsrelatedtomortgage
Amortizationofdeferredfinancingcostsrelatedtomortgage
33000 USD
gahr Amortizationofdeferredfinancingcostsrelatedtomortgage
Amortizationofdeferredfinancingcostsrelatedtomortgage
58000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-37000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-29000 USD
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
8166000 USD
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
459000 USD
gahr Capitalizeddeferredfinancingcostsformortgages
Capitalizeddeferredfinancingcostsformortgages
0 USD
gahr Capitalizeddeferredfinancingcostsformortgages
Capitalizeddeferredfinancingcostsformortgages
26000 USD
CY2020Q3 us-gaap Secured Debt
SecuredDebt
17974000 USD
CY2019Q3 us-gaap Secured Debt
SecuredDebt
26229000 USD
CY2020Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
151000 USD
CY2020Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
622000 USD
CY2020Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
651000 USD
CY2020Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
680000 USD
CY2020Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
711000 USD
CY2020Q3 gahr Long Term Debt Maturity After Year Four
LongTermDebtMaturityAfterYearFour
16118000 USD
CY2020Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
18933000 USD
CY2018Q4 gahr Swinglineloan
Swinglineloan
50000000 USD
CY2020Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
530000000 USD
CY2019Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
530000000 USD
CY2020Q3 us-gaap Line Of Credit
LineOfCredit
479500000 USD
CY2019Q4 us-gaap Line Of Credit
LineOfCredit
396800000 USD
CY2020Q3 us-gaap Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
1450000 USD
CY2019Q3 us-gaap Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
-402000 USD
us-gaap Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
-2302000 USD
us-gaap Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
-5401000 USD
CY2020Q3 gahr Amortizationof Identified Intangible Liabilities
AmortizationofIdentifiedIntangibleLiabilities
78000 USD
CY2019Q3 gahr Amortizationof Identified Intangible Liabilities
AmortizationofIdentifiedIntangibleLiabilities
212000 USD
gahr Amortizationof Identified Intangible Liabilities
AmortizationofIdentifiedIntangibleLiabilities
239000 USD
gahr Amortizationof Identified Intangible Liabilities
AmortizationofIdentifiedIntangibleLiabilities
421000 USD
gahr Finite Lived Intangible Liabilities Useful Life
FiniteLivedIntangibleLiabilitiesUsefulLife
P11Y7M6D
CY2019 gahr Finite Lived Intangible Liabilities Useful Life
FiniteLivedIntangibleLiabilitiesUsefulLife
P11Y3M18D
CY2020Q3 gahr Finite Lived Intangible Liabilities Amortization Expenses Remainder Of Fiscal Year
FiniteLivedIntangibleLiabilitiesAmortizationExpensesRemainderOfFiscalYear
66000 USD
CY2020Q3 gahr Finite Lived Intangible Liabilities Amortization Expenses Year Two
FiniteLivedIntangibleLiabilitiesAmortizationExpensesYearTwo
236000 USD
CY2020Q3 gahr Finite Lived Intangible Liabilities Amortization Expenses Year Three
FiniteLivedIntangibleLiabilitiesAmortizationExpensesYearThree
217000 USD
CY2020Q3 gahr Finite Lived Intangible Liabilities Amortization Expenses Year Four
FiniteLivedIntangibleLiabilitiesAmortizationExpensesYearFour
207000 USD
CY2020Q3 gahr Finite Lived Intangible Liabilities Amortization Expenses Year Five
FiniteLivedIntangibleLiabilitiesAmortizationExpensesYearFive
161000 USD
CY2020Q3 gahr Finite Lived Intangible Liabilities Amortization Expenses After Year Five
FiniteLivedIntangibleLiabilitiesAmortizationExpensesAfterYearFive
475000 USD
CY2020Q3 gahr Finite Lived Intangible Liabilities Net
FiniteLivedIntangibleLiabilitiesNet
1362000 USD
CY2019Q4 us-gaap Redeemable Noncontrolling Interest Equity Fair Value
RedeemableNoncontrollingInterestEquityFairValue
1462000 USD
CY2018Q4 us-gaap Redeemable Noncontrolling Interest Equity Fair Value
RedeemableNoncontrollingInterestEquityFairValue
1371000 USD
gahr Proceedsfromredeemablenoncontrollinginterest
Proceedsfromredeemablenoncontrollinginterest
1118000 USD
gahr Proceedsfromredeemablenoncontrollinginterest
Proceedsfromredeemablenoncontrollinginterest
151000 USD
gahr Paymentsto Redeemable Noncontrolling Interest
PaymentstoRedeemableNoncontrollingInterest
81000 USD
gahr Paymentsto Redeemable Noncontrolling Interest
PaymentstoRedeemableNoncontrollingInterest
0 USD
gahr Adjustmentsto Additional Paidin Capital Fair Value Adjustmentto Redeemable Noncontrolling Interests
AdjustmentstoAdditionalPaidinCapitalFairValueAdjustmenttoRedeemableNoncontrollingInterests
530000 USD
gahr Adjustmentsto Additional Paidin Capital Fair Value Adjustmentto Redeemable Noncontrolling Interests
AdjustmentstoAdditionalPaidinCapitalFairValueAdjustmenttoRedeemableNoncontrollingInterests
65000 USD
us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
332000 USD
us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
76000 USD
CY2020Q3 us-gaap Redeemable Noncontrolling Interest Equity Fair Value
RedeemableNoncontrollingInterestEquityFairValue
2697000 USD
CY2019Q3 us-gaap Redeemable Noncontrolling Interest Equity Fair Value
RedeemableNoncontrollingInterestEquityFairValue
1511000 USD
us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
15681000 USD
us-gaap Proceeds From Issuance Of Common Stock Dividend Reinvestment Plan
ProceedsFromIssuanceOfCommonStockDividendReinvestmentPlan
68311000 USD
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
200000000 shares
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
200000000 shares
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
7157430 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
105000 shares
gahr Common Stock Repuchased During Period Under Share Repurchase Plan Shares
CommonStockRepuchasedDuringPeriodUnderShareRepurchasePlanShares
1934950 shares
CY2020Q3 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
4247000 USD
us-gaap Proceeds From Issuance Of Common Stock Dividend Reinvestment Plan
ProceedsFromIssuanceOfCommonStockDividendReinvestmentPlan
52630000 USD
us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
7157430 shares
us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
5513699 shares
gahr Maximum Percentage Of Common Stock Repurchased During Period
MaximumPercentageOfCommonStockRepurchasedDuringPeriod
0.050
gahr Share Repurchase Plan Holding Period Condition One
ShareRepurchasePlanHoldingPeriodConditionOne
P1Y
gahr Share Repurchase Plan Holding Period Condition One
ShareRepurchasePlanHoldingPeriodConditionOne
P1Y
CY2020Q3 gahr Share Repurchase Plan Percentageof Priceper Share Condition One
ShareRepurchasePlanPercentageofPriceperShareConditionOne
0.925
CY2020Q3 gahr Share Repurchase Plan Percentageof Priceper Share Condition Two
ShareRepurchasePlanPercentageofPriceperShareConditionTwo
1
CY2020Q3 gahr Share Repurchase Plan Percentageof Priceper Share Condition Two
ShareRepurchasePlanPercentageofPriceperShareConditionTwo
1
CY2020Q3 gahr Common Stock Repuchased During Period Under Share Repurchase Plan Shares
CommonStockRepuchasedDuringPeriodUnderShareRepurchasePlanShares
71551 shares
CY2019Q3 gahr Common Stock Repuchased During Period Under Share Repurchase Plan Shares
CommonStockRepuchasedDuringPeriodUnderShareRepurchasePlanShares
308837 shares
CY2020Q3 gahr Stock Repuchased During Period Value Under Share Repurchase Plan Value
StockRepuchasedDuringPeriodValueUnderShareRepurchasePlanValue
706000 USD
CY2019Q3 gahr Stock Repuchased During Period Value Under Share Repurchase Plan Value
StockRepuchasedDuringPeriodValueUnderShareRepurchasePlanValue
2823000 USD
CY2020Q3 gahr Stock Acquired Average Cost Per Share
StockAcquiredAverageCostPerShare
9.87
CY2019Q3 gahr Stock Acquired Average Cost Per Share
StockAcquiredAverageCostPerShare
9.14
gahr Common Stock Repuchased During Period Under Share Repurchase Plan Shares
CommonStockRepuchasedDuringPeriodUnderShareRepurchasePlanShares
578111 shares
gahr Common Stock Repuchased During Period Under Share Repurchase Plan Shares
CommonStockRepuchasedDuringPeriodUnderShareRepurchasePlanShares
668646 shares
gahr Stock Repuchased During Period Value Under Share Repurchase Plan Value
StockRepuchasedDuringPeriodValueUnderShareRepurchasePlanValue
5349000 USD
gahr Stock Repuchased During Period Value Under Share Repurchase Plan Value
StockRepuchasedDuringPeriodValueUnderShareRepurchasePlanValue
6192000 USD
gahr Stock Acquired Average Cost Per Share
StockAcquiredAverageCostPerShare
9.25
gahr Stock Acquired Average Cost Per Share
StockAcquiredAverageCostPerShare
9.26
gahr Common Stock Repuchased During Period Under Share Repurchase Plan Shares
CommonStockRepuchasedDuringPeriodUnderShareRepurchasePlanShares
1934950 shares
gahr Common Stock Repuchased During Period Under Share Repurchase Plan Shares
CommonStockRepuchasedDuringPeriodUnderShareRepurchasePlanShares
1356839 shares
gahr Stock Repuchased During Period Value Under Share Repurchase Plan Value
StockRepuchasedDuringPeriodValueUnderShareRepurchasePlanValue
18005000 USD
gahr Stock Repuchased During Period Value Under Share Repurchase Plan Value
StockRepuchasedDuringPeriodValueUnderShareRepurchasePlanValue
12656000 USD
gahr Stock Acquired Average Cost Per Share
StockAcquiredAverageCostPerShare
9.31
gahr Stock Acquired Average Cost Per Share
StockAcquiredAverageCostPerShare
9.33
gahr Selling Commissions Percentage
SellingCommissionsPercentage
0.030
gahr Selling Commissions Expenses
SellingCommissionsExpenses
2241000 USD
gahr Maximumpercentageofdealermanagerfee
Maximumpercentageofdealermanagerfee
0.030
gahr Percentage Of Dealer Manager Fee
PercentageOfDealerManagerFee
0.010
gahr Maximumpercentageofdealermanagerfee
Maximumpercentageofdealermanagerfee
0.030
gahr Percentage Of Dealer Manager Fee
PercentageOfDealerManagerFee
0.010
gahr Dealer Manager Fees
DealerManagerFees
759000 USD
gahr Stockholderdailyservicingfeepercentage
Stockholderdailyservicingfeepercentage
0.010
gahr Maximumpercentageofstockholderservicingfee
Maximumpercentageofstockholderservicingfee
0.040
gahr Stockholder Servicing Fee Incurred
StockholderServicingFeeIncurred
2536000 USD
CY2020Q3 gahr Stockholder Servicing Fee Payable
StockholderServicingFeePayable
7667000 USD
CY2019Q4 gahr Stockholder Servicing Fee Payable
StockholderServicingFeePayable
12610000 USD
CY2020Q3 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
3045000 USD
CY2019Q3 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
4478000 USD
us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
10344000 USD
us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
12626000 USD
gahr Maximumpercentageofdealermanagerfee
Maximumpercentageofdealermanagerfee
0.030
gahr Percentage Of Dealer Manager Fee
PercentageOfDealerManagerFee
0.010
gahr Maximumpercentageofdealermanagerfee
Maximumpercentageofdealermanagerfee
0.030
gahr Percentage Of Dealer Manager Fee
PercentageOfDealerManagerFee
0.010
gahr Maximum Percentage Of Fees And Expenses Associated With Acquisition
MaximumPercentageOfFeesAndExpensesAssociatedWithAcquisition
0.060
gahr Maximum Percentage Of Fees And Expenses Associated With Acquisition
MaximumPercentageOfFeesAndExpensesAssociatedWithAcquisition
0.060
gahr Maximum Percentage Of Fees And Expenses Associated With Acquisition
MaximumPercentageOfFeesAndExpensesAssociatedWithAcquisition
0.060
CY2017Q4 gahr Minimum Investment Rate By Officer Evp
MinimumInvestmentRateByOfficerEVP
0.050
CY2017Q4 gahr Maximum Investment Rate By Officer Evp
MaximumInvestmentRateByOfficerEVP
0.150
CY2019Q4 us-gaap Secured Debt
SecuredDebt
26070000 USD
CY2019Q4 us-gaap Loans Payable Fair Value Disclosure
LoansPayableFairValueDisclosure
26677000 USD
CY2020Q3 us-gaap Due To Affiliate Current And Noncurrent
DueToAffiliateCurrentAndNoncurrent
987000 USD
CY2019Q4 us-gaap Due To Affiliate Current And Noncurrent
DueToAffiliateCurrentAndNoncurrent
1016000 USD
CY2020Q3 us-gaap Secured Debt
SecuredDebt
17974000 USD
CY2020Q3 us-gaap Loans Payable Fair Value Disclosure
LoansPayableFairValueDisclosure
21944000 USD
CY2020Q3 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-37000 USD
CY2020Q3 gahr Linesofcreditandtermloannet
Linesofcreditandtermloannet
477306000 USD
CY2020Q3 us-gaap Line Of Credit Facility Fair Value Of Amount Outstanding
LineOfCreditFacilityFairValueOfAmountOutstanding
480348000 USD
CY2019Q4 gahr Linesofcreditandtermloannet
Linesofcreditandtermloannet
393217000 USD
CY2019Q4 us-gaap Line Of Credit Facility Fair Value Of Amount Outstanding
LineOfCreditFacilityFairValueOfAmountOutstanding
396891000 USD
CY2020Q3 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-863000 USD
CY2019Q3 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-290000 USD
us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-2134000 USD
us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-958000 USD
CY2020Q3 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-327000 USD
CY2019Q3 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-68000 USD
us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-721000 USD
us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-250000 USD
CY2019Q3 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2019Q3 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
16000 USD
CY2019Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
19253000 USD
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2020Q3 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-2000 USD
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0 USD
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
26000 USD
CY2020Q3 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
1190000 USD
CY2019Q3 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
349000 USD
us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
2855000 USD
us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
1199000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-39000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17000 USD
CY2020Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
21519000 USD
CY2020Q3 us-gaap Variable Lease Cost
VariableLeaseCost
4592000 USD
CY2019Q3 us-gaap Variable Lease Cost
VariableLeaseCost
3718000 USD
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
64824000 USD
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
53280000 USD
us-gaap Variable Lease Cost
VariableLeaseCost
13861000 USD
us-gaap Variable Lease Cost
VariableLeaseCost
10426000 USD
CY2020Q3 us-gaap Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year
LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear
16049000 USD
CY2020Q3 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
64178000 USD
CY2020Q3 us-gaap Lessor Operating Lease Payments To Be Received Two Years
LessorOperatingLeasePaymentsToBeReceivedTwoYears
61520000 USD
CY2020Q3 us-gaap Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
57017000 USD
CY2020Q3 us-gaap Lessor Operating Lease Payments To Be Received Four Years
LessorOperatingLeasePaymentsToBeReceivedFourYears
51410000 USD
CY2020Q3 gahr Lessor Operating Lease Payment To Be Received After Year Four
LessorOperatingLeasePaymentToBeReceivedAfterYearFour
310613000 USD
CY2020Q3 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
560787000 USD
CY2020Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
206000 USD
CY2019Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
177000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
643000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
478000 USD
CY2020Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P79Y8M12D
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P80Y4M24D
CY2020Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0574
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0574
us-gaap Operating Lease Payments
OperatingLeasePayments
306000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
252000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
4489000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
212000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
523000 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3672000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
534000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
526000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
530000 USD
CY2020Q3 gahr Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
47103000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
49428000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
39453000 USD
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
9975000 USD
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
4 segment
CY2020Q3 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
21519000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18948000 USD
CY2020Q3 gahr Government Grant Income From Cares Act
GovernmentGrantIncomeFromCARESAct
864000 USD
CY2020Q3 gahr Revenuesand Government Grant Income From Cares Act
RevenuesandGovernmentGrantIncomeFromCARESAct
41331000 USD
CY2020Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
5905000 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
17397000 USD
CY2020Q3 gahr Segmentnetoperatingincome
Segmentnetoperatingincome
18029000 USD
CY2020Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
57000 USD
CY2020Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
12669000 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
4839000 USD
CY2020Q3 us-gaap Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
1450000 USD
CY2020Q3 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
3064000 USD
CY2020Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-377000 USD
CY2020Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
8000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5191000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-39000 USD
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-5152000 USD
CY2019Q3 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
19253000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11865000 USD
CY2019Q3 gahr Revenuesand Government Grant Income From Cares Act
RevenuesandGovernmentGrantIncomeFromCARESAct
31118000 USD
CY2019Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
4929000 USD
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9884000 USD
CY2019Q3 gahr Segmentnetoperatingincome
Segmentnetoperatingincome
16305000 USD
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3982000 USD
CY2019Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
74000 USD
CY2019Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
9552000 USD
CY2019Q3 us-gaap Interest Expense
InterestExpense
4140000 USD
CY2019Q3 us-gaap Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
-402000 USD
CY2019Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-79000 USD
CY2019Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
13000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1911000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7000 USD
CY2019Q3 us-gaap Profit Loss
ProfitLoss
-1918000 USD
us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
64824000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
51863000 USD
gahr Government Grant Income From Cares Act
GovernmentGrantIncomeFromCARESAct
864000 USD
gahr Revenuesand Government Grant Income From Cares Act
RevenuesandGovernmentGrantIncomeFromCARESAct
117551000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
17723000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
44856000 USD
gahr Segmentnetoperatingincome
Segmentnetoperatingincome
54972000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11960000 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
74000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
37919000 USD
us-gaap Interest Expense
InterestExpense
15123000 USD
us-gaap Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
-2302000 USD
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
3064000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
952000 USD
us-gaap Interest And Other Income
InterestAndOtherIncome
278000 USD
us-gaap Profit Loss
ProfitLoss
-14240000 USD
us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
53280000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34053000 USD
gahr Revenuesand Government Grant Income From Cares Act
RevenuesandGovernmentGrantIncomeFromCARESAct
87333000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
14238000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
28194000 USD
gahr Segmentnetoperatingincome
Segmentnetoperatingincome
44901000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11413000 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
1492000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
35561000 USD
us-gaap Interest Expense
InterestExpense
11532000 USD
us-gaap Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
-5401000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
185000 USD
us-gaap Interest And Other Income
InterestAndOtherIncome
162000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-20151000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17000 USD
us-gaap Profit Loss
ProfitLoss
-20168000 USD
CY2020Q3 us-gaap Assets
Assets
1111490000 USD
CY2019Q4 us-gaap Assets
Assets
1068327000 USD
CY2020Q3 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
1 State
CY2020Q3 gahr Minimum Percent Share Of Each State Annualized Base Rent That Company Owned
MinimumPercentShareOfEachStateAnnualizedBaseRentThatCompanyOwned
0.100
CY2020Q3 gahr Number Of Tenants With More Than Ten Percent Of Annual Base Rent
NumberOfTenantsWithMoreThanTenPercentOfAnnualBaseRent
1 tenant
CY2020Q3 gahr Minimum Percent Share Of Annualized Base Rent Accounted By Tenants
MinimumPercentShareOfAnnualizedBaseRentAccountedByTenants
0.100
CY2020Q3 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
4000 USD
CY2019Q3 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
7000 USD
us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
15000 USD
us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
18000 USD

Files In Submission

Name View Source Status
0001632970-20-000075-index-headers.html Edgar Link pending
0001632970-20-000075-index.html Edgar Link pending
0001632970-20-000075.txt Edgar Link pending
0001632970-20-000075-xbrl.zip Edgar Link pending
ex311-gahr4x10xq2020xq3.htm Edgar Link pending
ex312-gahr4x10xq2020xq3.htm Edgar Link pending
ex321-gahr4x10xq2020xq3.htm Edgar Link pending
ex322-gahr4x10xq2020xq3.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gahr-20200930.htm Edgar Link pending
gahr-20200930.xsd Edgar Link pending
gahr-20200930_cal.xml Edgar Link unprocessable
gahr-20200930_def.xml Edgar Link unprocessable
gahr-20200930_htm.xml Edgar Link completed
gahr-20200930_lab.xml Edgar Link unprocessable
gahr-20200930_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending